SAB Biotherapeutics (SABS) Return on Sales (2021 - 2024)
SAB Biotherapeutics (SABS) reported Return on Sales of 0.87% for Q4 2024, down 12.0% on a YoY basis from 0.99% in Q1 2024, and down 187.79% quarter-over-quarter from 0.3% in Q3 2024.
SAB Biotherapeutics (SABS) Return on Sales (2021 - 2024) Analysis & Trends
SAB Biotherapeutics has reported Return on Sales for 4 years, with the latest figure at 0.87% in Q4 2024.
- For the quarter ending Q4 2024, Return on Sales fell 12.0% year-over-year to 0.87%; the trailing twelve-month figure through Dec 2024 stood at 0.25% (down 6.0% YoY), and the FY2024 full-year result was 0.32%, down 13.0% from the prior year.
- Return on Sales for Q4 2024 stood at 0.87%, down from 0.3% in the prior quarter.
- The five-year high for Return on Sales was 0.0% in Q1 2022, with the low at 0.87% in Q4 2024.
- Historically, Return on Sales has averaged 0.21% across 4 years, with a median of 0.04% in 2022.
- Annual changes were most pronounced in 2023 — Return on Sales slumped 80 bps — and 2024, when it jumped 53 bps.
- SAB Biotherapeutics' Return on Sales stood at 0.01% in 2021, then plunged by 248 bps to 0.04% in 2022, then sank by 1963 bps to 0.75% in 2023, then decreased by 16 bps to 0.87% in 2024.
- The last three Return on Sales figures came in at 0.87% (Q4 2024), 0.3% (Q3 2024), and 0.28% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SAB Biotherapeutics | 214.77 Mn | 214.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.87% |
| Sep 30, 2024 | -0.30% |
| Jun 30, 2024 | -0.28% |
| Mar 31, 2024 | -0.05% |
| Dec 31, 2023 | -0.75% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.80% |
| Mar 31, 2023 | -0.13% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |